Member Info for Tillywhiz

Check , hedge & all

We are all on the same lth Hemo investor team & also know how spectacular Hemo science could potentially be if does what says on the tin & will drive the stock price north , to where who knows .

Enjoy your evening all invested it’s another good day 👍🍷

Hedge , & all

Many times in the early days he said avoid as well

Each to their own but not my cup of tea .

10% Better than a mouthful of wasps

Money flowing in following the science 👍🍷

Hemo science , if does what says on the tin

Big money will flow in for sure & already started in my opinion 👍🍷

More like Zack , sack & talks out of his crack

He’s the best hindsight trader there is , didn’t see him backing Hemo at 1.3 like many lth s

Current numbers whilst having my Full English with all the trimmings 👍⚓️

Price 1300 + 12%

Current 1237-1295

Volume 27000

Vwap 1260 on the turn

Spread 7%

Looking good as the north trajectory continues in low volume with Hemo science sailing the ship north into blue waters .

News rich period to continue, Lovely Jubbly 👍🍷

Hay & all

Excellent, institutions getting their cheque books out .

Hemo science unravelling & doing what it says on the tin & stock price tracking the news 👍

Short term good , medium term superb & Long term Biblical 🍷👍

Jesus all the toxic lowlifes are out of the swamp this morning

All bought in after slating Hemo for months .

Current live

1230 - 1330

Hemo science putting the umph into the stock price

Nice follow up rise now news digested 👍

Like toxic boomerangs they keep coming back

Morning all invested

Some good posts & information/ opinion sharing last evening, great to see & all here to see Hemo science unfold & our investments continue to flourish .

Without the toxicity from the few rogue mudskippers , doubt it will last mind …

News rich period & Hemo science fully unravelling, great to see for all invested especially lths held stock here for 10 yrs & have a large holding , 👍

In fact

Been invested that long , When I first invested the Mrs boobs stuck out & had hair down to her ass , now her hair sticks up & her boobs are down to her waist. 🤔😂

Onwards & upwards .

If Hemo science continues to do what it says on the tin , through the clinical trials ,

Then certainly could see some sort of financial involvement from a pharma or investor , perhaps as early as Xmas , that would suffice for all invested .to start with .

Another great RNS as Hemo science unravels through clinical 👍

Price 1135 - ( actual 1168 )

Last two trades indicates mid price as Vwap 1168

Value

06-Oct-25 16:29:31 1,191.40 3 Buy* 1,135.00 1,195.00 35.74 O

06-Oct-25 16:26:56 1,135.00 31 Sell* 1,135.00 1,195.00 351.85 A

Volume 55000

Vwap 1168

Spread 6%

News rich period continues for all invested 👍🍷

Hemogenyx secures clearance for pediatric enrolment in leukemia trial

Alliance News

6th Oct 14:22

-Hemogenyx Pharmaceuticals PLC on Monday said it has received clearance to begin pediatric enrolment in its phase 1 trial of a leukemia treatment. The London- headquartered biopharmaceutical company focused on treatments for blood diseases said the institutional review board at MD Anderson Cancer Centre approved an amendment to the clinical protocol of...

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Monday said it has received clearance to begin pediatric enrolment in its phase 1 trial of a leukemia treatment.

The London-headquartered biopharmaceutical company focused on treatments for blood diseases said the institutional review board at MD Anderson Cancer Centre approved an amendment to the clinical protocol of the company's ongoing trial for HG-CT-1.

The approved amendment expands the eligibility criteria for the trial to include children and adolescents, which broadens the patient pool and builds on the safety and early efficacy signals already observed in adult participants.

HG-CT-1 is Hemogenyx's CAR-T cell therapy for the treatment of relapsed or refractory acute myeloid leukemia.

"Securing IRB clearance to proceed with pediatric enrolment in our HG-CT-1 clinical trial is a major milestone.

It marks the transition of HG-CT-1 into the pediatric setting, where treatment options remain limited, and demonstrates the continued momentum of our development program," said Hemogenyx Chief Executive Officer Vladislav Sandler.

"This expansion not only increases the potential reach and impact of HG-CT-1 but also underscores the value of the company's strong intellectual property portfolio, which underpins our pipeline and supports long-term growth."

The company will provide further updates as both adult and pediatric patient enrolment progresses.

Shares in Hemogenyx Pharmaceuticals were up 7.7% at 1,162.89 pence in London on Monday afternoon.

The stock has more than doubled from 526.40p .

Great to see Hemo continue to gain traction for its superb science. 👍

Don’t worry yourself , your not invested in Hemo .

Now chop chop the karzy won’t clean itself

No one is interested Boom ,

Now make yourself useful & go and give the dunny a once over .

The more science information & clinical hurdles jumped by Hemo the more the big pharmas & investors will take notice ,

Investor conference just finished , & ASH conference coming .

After the recent RNS clearly stating Hemo science map , the pharmas will be licking their lips at Hemo data with cheque books at the ready .

Good times ahead for all invested 👍🍷

Expect some large delayed kipper trades later

Been filling some orders this morning with a close around the vwap of 1175 ish.